News
Excerpted with permission from Our Future is Biotech: A Plain English Guide to How a Tech Revolution is Changing Our Lives ...
17h
MoneyWeek on MSNCash in on the biotech boom with three promising European picksAilsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...
This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...
Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.
Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...
Despite the long holiday weekend, news in biopharma never slows down. | This week on "The Top Line," we break down ...
17h
Investor's Business Daily on MSNSummit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile FailureSummit Therapeutics stock plunged Friday after its highly watched cancer drug failed to significantly improve overall survival.
Asset Entities is a Strong Buy after $750M funding, a strategic merger, and investor confidence at a 121% premium. Read why ...
Summit has been a tremendous winner over the past year, as its bispecific antibody lung cancer drug ivonescimab outperformed ...
Regeneron and Sanofi face setbacks as itepekimab stumbles in phase 3. Click here to read why I believe SNY and REGN stocks ...
The US issued a ban on Xinjiang cotton imports in 2020. It was extended to a region-wide prohibition the following year, ...
PharmAla Biotech (CSE:MDMA) issued a public warning after discovering that unknown parties are illegally marketing a nasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results